Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Barrett Esophagus 1

Interventions

Fluorouracil 11Cisplatin 10Radiotherapy 9Paclitaxel 7Trastuzumab 5Erlotinib Hydrochloride 5Specimen Handling 4Taxes 3Radiation 3Nivolumab 3Magnetic Resonance Spectroscopy 3Leucovorin 3Irinotecan 3Carboplatin 3trastuzumab biosimilar HLX02 2entinostat 2alvocidib 2Psychiatric Rehabilitation 2Plicamycin 2PF-05280014 2Oxaliplatin 2Ontruzant 2Ogivri 2Neoadjuvant Therapy 2Microarray Analysis 2Epirubicin 2Decitabine 2Celecoxib 2CT-P6 2Brachytherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Esophageal Neoplasms × Esomeprazole × Clear all
NCT00474903 2014-07-02

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

National Cancer Institute (NCI)

Phase 2 Completed
122 enrolled 6 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡